MedPath

Investigating the effect of zinc on pulmonary function in adults with cystic fibrosis

Phase 3
Recruiting
Conditions
Cystic fibrosis.
Cystic fibrosis
Registration Number
IRCT20231203060254N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

They have a history of suffering from cystic fibrosis, which was confirmed by genetic tests that have been done before

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spirometry test is performed and its results of fev1, fvc, RV, tlc are statistically compared in 2 groups. Timepoint: Finally after 3 months. Method of measurement: Spirometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath